Secondary analysis of the RICCADSA trial: of 119 revascularised CAD patients with untreated moderate-to-severe OSA, 61.3% improved in OSA severity at 1 year; improvers had lower MACCE risk than those with persistent OSA (HR 0.25).
Secondary analysisn = 119
Peker et al. Natural course of untreated obstructive sleep apnea in adults with coronary artery disease in the RICCADSA cohort